![2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid](https://static.cymitquimica.com/products/3D/img/FM102909.png "Clique para ampliar")
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid
CAS: 1372540-25-4
Ref. 3D-FM102909
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Informação sobre produto
2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid (BIC) is a strain that is categorized as a cancer drug. It has been synthesized in the laboratory and has been shown to bind to the bRaf protein, inhibiting its activity. BIC is also known as a stereoisomer because it has two different forms, L and D. The symbol for this drug is "BIC". This drug discriminates between healthy cells and cancer cells by selectively targeting those with mutated bRaf proteins. The parameter of this drug that is quantized is its effect on cancer cells. BIC's virulent effects may be due to its ability to inhibit the synthesis rate of antibodies in the body.
Propriedades químicas
Consulta técnica sobre: 3D-FM102909 2-Methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
